Buy ERBITUX 2 MG CETUXIMAB

ERBITUX 2 MG is a solution for intravenous use, containing cetuximab. It is used in cancer treatment and may help slow tumor growth. Learn more about its uses and effects.

Strength

2 MG

Pack Size

50ML

Manufacturer / TM Owner

IMCLONE, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ERBITUX 2 MG is primarily used in the treatment of certain types of cancer. Cetuximab, the active ingredient, is designed to target specific proteins on cancer cells, potentially helping to slow tumor growth. This medication is often used in combination with other cancer treatments. What is ERBITUX 2 MG used for? It is typically prescribed for advanced or metastatic cancers, including head and neck cancer and colorectal cancer.

Side Effects

Common effects of ERBITUX 2 MG may include skin reactions, such as acne-like rashes or itching. Some individuals may also experience fatigue, nausea, or vomiting. These effects can vary from person to person and are not experienced by everyone who uses this medication.

Precautions & Warnings

ERBITUX 2 MG should be handled with care and administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before starting treatment. This medication should be stored and used according to the instructions provided by your healthcare provider.

Avoid Interactions

ERBITUX 2 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, certain medical conditions may affect the safety and effectiveness of this medication.

References

Frequently Asked Questions

ERBITUX 2 MG is used in the treatment of certain types of cancer, including head and neck cancer and colorectal cancer.

ERBITUX 2 MG is administered intravenously by a healthcare professional.

Common side effects may include skin reactions, fatigue, nausea, and vomiting.

It is important to discuss all current medications with your healthcare provider to avoid potential interactions.

Inform your healthcare provider about any allergies or medical conditions before starting treatment.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.